LOW-DOSE LENALIDOMIDE IN ADDITION TO LOW-DOSE CYTARABINE INDUCES LONG-LASTING COMPLETE REMISSIONS IN A SUBSTANTIAL PROPORTION OF VERY ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS WITH UNFAVORABLE KARYOTYPE

被引：0
|
作者：
Visani, G. [1 ]
Ferrara, F. [2 ]
Di Raimondo, F. [3 ]
Caraci, M. [3 ]
Izzo, T. [2 ]
Riccardi, C. [2 ]
Barulli, S. [1 ]
Guiducci, B. [1 ]
Loscocco, F. [1 ]
Ricciardi, T. [1 ]
Sparaventi, G. [1 ]
Isidori, A. [1 ]
机构：
[1] Hematol & Stem Cell Transplant Ctr, Pesaro, Italy
[2] Cardarelli Hosp, Hematol, Naples, Italy
[3] Catania Univ, Hematol, Catania, Italy
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0057
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] LOW-DOSE LENALIDOMIDE COUPLED with LOW-DOSE Cytarabine INDUCES COMPLETE REMISSION of Elderly ACUTE Myeloid LEUKEMIA PATIENTS with Unfavorable Citogenetics: PRELIMINARY RESULTS of A PHASE II STUDY
    Visani, Giuseppe
    Ferrara, Felicetto
    Di Raimondo, Francesco
    Caraci, Maria Rita
    Izzo, Tiziana
    Barulli, Sara
    Guiducci, Barbara
    Loscocco, Federica
    Ricciardi, Teresa
    Sparaventi, Giovanni
    Isidori, Alessandro
    BLOOD, 2011, 118 (21) : 1549 - 1549
  • [2] Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients
    Visani, Giuseppe
    Di Raimondo, Francesco
    Ferrara, Felicetto
    Loscocco, Federica
    Piccaluga, Pier Paolo
    Fuligni, Fabio
    Gazzola, Anna
    Rossi, Maura
    Laginestra, Antonella
    Caraci, Maria Rita
    Riccardi, Cira
    Visani, Axel
    Barulli, Sara
    Guiducci, Barbara
    Ricciardi, Teresa
    Sparaventi, Giovanni
    Rocchi, Marco
    Isidori, Alessandro
    BLOOD, 2013, 122 (21)
  • [3] LOW-DOSE LENALIDOMIDE PLUS LOW DOSE CYTARABINE INDUCE COMPLETE REMISSION THAT CAN BE PREDICTED BY GENETIC PROFILING IN VERY ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
    Isidori, A.
    Ferrara, F.
    Di Raimondo, F.
    Loscocco, F.
    Piccaluga, P. Paolo
    Fuligni, F.
    Gazzola, A.
    Rossi, M.
    Laginestra, A.
    Caraci, M.
    Izzo, T.
    Riccardi, C.
    Barulli, S.
    Guiducci, B.
    Picardi, P.
    Ricciardi, T.
    Sparaventi, G.
    Rocchi, M.
    Visani, G.
    HAEMATOLOGICA, 2013, 98 : 246 - 246
  • [4] LOW-DOSE CYTARABINE IN ACUTE MYELOID-LEUKEMIA
    MANOHARAN, A
    LEYDEN, MJ
    SULLIVAN, J
    MEDICAL JOURNAL OF AUSTRALIA, 1984, 141 (10) : 643 - 646
  • [5] Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study
    Visani, Giuseppe
    Ferrar, Felicetto
    Di Raimondo, Francesco
    Loscocco, Federica
    Fuligni, Fabio
    Paolini, Stefania
    Zammit, Valentina
    Spina, Eleonora
    Rocchi, Marco
    Visani, Axel
    Piccaluga, Pier Paolo
    Isidori, Alessandro
    LEUKEMIA RESEARCH, 2017, 62 : 77 - 83
  • [6] Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients
    Visani, G.
    Ferrara, F.
    Di Raimondo, F.
    Loscocco, F.
    Sparaventi, G.
    Paolini, S.
    Fuligni, F.
    Gazzola, A.
    Rossi, M.
    Laginestra, M. A.
    Caraci, M. R.
    Riccardi, C.
    Rocchi, M.
    Visani, A.
    Pileri, S. A.
    Piccaluga, P. P.
    Isidori, A.
    LEUKEMIA, 2014, 28 (04) : 967 - 970
  • [7] Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients
    G Visani
    F Ferrara
    F Di Raimondo
    F Loscocco
    G Sparaventi
    S Paolini
    F Fuligni
    A Gazzola
    M Rossi
    M A Laginestra
    M R Caraci
    C Riccardi
    M Rocchi
    A Visani
    S A Pileri
    P P Piccaluga
    A Isidori
    Leukemia, 2014, 28 : 967 - 970
  • [8] MAINTENANCE WITH LOW-DOSE CYTARABINE FOR ACUTE MYELOID-LEUKEMIA IN COMPLETE REMISSION
    ARCHIMBAUD, E
    ANGLARET, B
    THOMAS, X
    JAUBERT, J
    SEBBAN, C
    GUYOTAT, D
    FIERE, D
    ANNALS OF HEMATOLOGY, 1992, 65 (02) : 71 - 74
  • [9] LOW-DOSE CYTARABINE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA
    BERIS, P
    RIEDER, A
    ANDREY, C
    HELG, C
    CHAPUIS, B
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 114 (48) : 1763 - 1766
  • [10] TREATMENT OF ACUTE MYELOID-LEUKEMIA IN THE ELDERLY WITH LOW-DOSE CYTARABINE, HYDROXYUREA, AND CALCITRIOL
    SLAPAK, CA
    DESFORGES, JF
    FOGAREN, T
    MILLER, KB
    AMERICAN JOURNAL OF HEMATOLOGY, 1992, 41 (03) : 178 - 183
12345